Miroculus Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
26
- Latest Deal Type
-
M&A
Miroculus General Information
Description
Developer of microRNA profiling technology designed to detect genetic fragments in the blood or tissue. The company's platform leverages a proprietary digital microfluidics technology to automate manually intensive experimental workflows on a low-cost cartridge, enabling medical practitioners to have access to accurate, affordable, and minimally invasive molecular testing.
Contact Information
Website
www.miroculus.comCorporate Office
- 458 Brannan Street
- Office 118
- San Francisco, CA 94107
- United States
Corporate Office
- 458 Brannan Street
- Office 118
- San Francisco, CA 94107
- United States
Miroculus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Merger/Acquisition | 15-Mar-2023 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 26-Sep-2022 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series B) | 11-Feb-2021 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 26-May-2020 | Completed | Generating Revenue | |||
| 8. Debt - PPP | 27-Apr-2020 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | 12-Nov-2018 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series A) | 31-Oct-2016 | Completed | Startup | |||
| 5. Accelerator/Incubator | 13-Jun-2016 | Completed | Startup | |||
| 4. Seed Round | 01-Aug-2015 | $4.75M | $4.75M | Completed | Startup | |
| 3. Grant | 27-Oct-2013 | $125K | Completed | Startup |
Miroculus Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B2 | ||||||||
| Series B1 | ||||||||
| Series B | 8,010,003 | $0.000010 | $0.16 | $3.17 | $3.17 | 1x | $3.17 | 23.92% |
| Seed | 2,622,200 | $0.000010 | $0.1 | $1.95 | $1.95 | 1x | $1.95 | 7.83% |
Miroculus Comparisons
Industry
Financing
Details
Miroculus Competitors (15)
One of Miroculus’s 15 competitors is Autogenomics, a Formerly VC-backed company based in Carlsbad, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Autogenomics | Formerly VC-backed | Carlsbad, CA | ||||
| Caris Life Sciences | Formerly PE-Backed | Irving, TX | ||||
| DNAe | Formerly VC-backed | London, United Kingdom | ||||
| Genomic Expression | Venture Capital-Backed | Beverly, MA | ||||
| Agendia | Venture Capital-Backed | Irvine, CA |
Miroculus Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Miroculus Patents
Miroculus Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250153182-A1 | Air-matrix digital microfluidics apparatuses and methods for limiting evaporation and surface fouling | Pending | 16-Jan-2025 | ||
| US-20250011700-A1 | Microfluidic two-dimensional capillary manipulation devices and methods | Pending | 07-Jul-2023 | ||
| WO-2025014899-A1 | Microfluidic two-dimensional capillary manipulation devices and methods | Inactive | 07-Jul-2023 | ||
| WO-2023240241-A2 | Hydrophobic cartridge for digital microfluidics | Inactive | 09-Jun-2022 | ||
| WO-2023240241-A3 | Hydrophobic cartridge for digital microfluidics | Inactive | 09-Jun-2022 | B01L3/502707 |
Miroculus Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Miroculus Former Investors (25)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 0BS (Mexico) | Venture Capital | Minority | ||
| Cota Capital | Venture Capital | Minority | ||
| Crown Holding | Growth/Expansion | Minority | ||
| Endeavor Catalyst | Venture Capital | Minority | ||
| Endeavor Greece | Accelerator/Incubator | Minority |
Miroculus Acquisitions (1)
Miroculus’s most recent deal was a Merger/Acquisition with Kapplex. The deal was made on 03-May-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Kapplex | 03-May-2016 | Merger/Acquisition | Diagnostic Equipment |
Miroculus FAQs
-
When was Miroculus founded?
Miroculus was founded in 2013.
-
Where is Miroculus headquartered?
Miroculus is headquartered in San Francisco, CA.
-
What is the size of Miroculus?
Miroculus has 26 total employees.
-
What industry is Miroculus in?
Miroculus’s primary industry is Discovery Tools (Healthcare).
-
Is Miroculus a private or public company?
Miroculus is a Private company.
-
What is Miroculus’s current revenue?
The current revenue for Miroculus is .
-
How much funding has Miroculus raised over time?
Miroculus has raised $57.3M.
-
Who are Miroculus’s investors?
0BS (Mexico), Cota Capital, Crown Holding, Endeavor Catalyst, and Endeavor Greece are 5 of 25 investors who have invested in Miroculus.
-
Who are Miroculus’s competitors?
Autogenomics, Caris Life Sciences, DNAe, Genomic Expression, and Agendia are some of the 15 competitors of Miroculus.
-
When was Miroculus acquired?
Miroculus was acquired on 15-Mar-2023.
-
Who acquired Miroculus?
Miroculus was acquired by Integra Biosciences (Switzerland).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
